SPAIN - ERA Biotech raises EUR 1.4m from private equity investors
Bioproductivity company ERA Biotech has raised EUR 1.4m to finance its activities related to the manufacture of recombinant proteins in cultured cells.
Invertec, Reus Capital Riesgo, Talde Capital II and Uninvest each invested EUR 300,000 in convertible loans in the round, which also included participation by individuals and entities close to the company. ERA Biotech will use the funds to continue the commercial deployment of its bioproductivity manufacturing solutions, to augment the downstream processing gains they deliver, and to initiate the development of proprietary products.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds
Back to Top








